{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:12:06Z","timestamp":1778548326247,"version":"3.51.4"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,9,13]],"date-time":"2005-09-13T00:00:00Z","timestamp":1126569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:p><jats:bold>Abstract: Background\/Aim:<\/jats:bold>Expression alteration of<jats:italic>Glypican\u20103<\/jats:italic>(<jats:italic>GPC3<\/jats:italic>) is associated with several malignancies and has been identified as an overexpressed gene in hepatocellular carcinoma (HCC). In this study<jats:italic>GPC3<\/jats:italic>expression in intrahepatic chanlangiocarcinoma (ICC), gallbladder cancer and HCC was quantitatively detected.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>Real\u2010time quantitative reverse transcription polymerase chain reaction was used to detect the expression level of<jats:italic>GPC3<\/jats:italic>.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold><jats:italic>GPC3<\/jats:italic>expression was elevated more than two\u2010fold in HCC compared with adjacent tissue in 90 of 100 HCC cases. The average expression level of<jats:italic>GPC3<\/jats:italic>was significantly higher in HCC than that in adjacent liver tissues (<jats:italic>P<\/jats:italic>&lt;0.0001). Only in four of 21 ICC cases<jats:italic>GPC3<\/jats:italic>expression was upregulated more than two\u2010fold in tumor tissues.<jats:italic>GPC3<\/jats:italic>expression was downregulated in gallbladder cancer in 12 of 13 cases and the average expression level was significantly lower than that in normal gallbladder tissues (<jats:italic>P<\/jats:italic>&lt;0.05).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold>The different expression patterns of<jats:italic>GPC3<\/jats:italic>in HCC and ICC suggested that it might play a different role in theses tumors and could serve as a biomarker for differential diagnosis of HCC and ICC.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2005.01100.x","type":"journal-article","created":{"date-parts":[[2005,9,13]],"date-time":"2005-09-13T08:00:44Z","timestamp":1126598444000},"page":"962-966","source":"Crossref","is-referenced-by-count":47,"title":["Upregulation of<i>Glypican\u20103<\/i>expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers"],"prefix":"10.1111","volume":"25","author":[{"given":"Xiao\u2010Bo","family":"Man","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao\u2010Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen\u2010Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu\u2010Hua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng\u2010Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong\u2010Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,9,13]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0802-339"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300204"},{"issue":"5","key":"e_1_2_6_4_2","first-page":"961","article-title":"Cholangiocarcinoma","volume":"37","author":"Gores G J.","year":"2003","journal-title":"current concepts and insights"},{"issue":"4","key":"e_1_2_6_5_2","first-page":"497","article-title":"Glypicans","volume":"108","author":"Filmus J","year":"2001","journal-title":"proteoglycans with a surprise"},{"key":"e_1_2_6_6_2","first-page":"3","article-title":"Expression of OCI\u20105\/Glypican3 during intestinal morphogenesis","volume":"235","author":"Li M","year":"1997","journal-title":"regulation by cell shape in intestinal epithelial cells"},{"issue":"3","key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1016-8478(23)13749-6","article-title":"Blocking endogenous glypican\u20103 expression releases Hep 3B cells from G1 arrest","volume":"15","author":"Farooq M","year":"2003","journal-title":"Mol Cells"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0396-241"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203322"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204925"},{"issue":"4","key":"e_1_2_6_11_2","first-page":"807","article-title":"Frequent silencing of the GPC3 gene in ovarian cancer cell lines","volume":"59","author":"Lin H","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.3_suppl.6S"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2003-0061OC"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024549729256"},{"key":"e_1_2_6_15_2","first-page":"5179","article-title":"Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma","volume":"15","author":"Hsu H C","year":"1997","journal-title":"biological significance and temporospatial distribution"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v6.i1.57"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.48.4.558"},{"issue":"1","key":"e_1_2_6_18_2","first-page":"89","article-title":"Glypican\u20103","volume":"125","author":"Capurro M","year":"2003","journal-title":"a novel serum and histochemical marker for hepatocellular carcinoma"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2003.tb01430.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)00908-2"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10856"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.25087"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-002-0729-3"},{"issue":"12","key":"e_1_2_6_24_2","first-page":"1144","article-title":"High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma","volume":"38","author":"Abe N","year":"2003","journal-title":"its potential use in the diagnosis of liver neoplasms"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2003.10.023"},{"issue":"2","key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00129039-200006000-00006","article-title":"MOC31 immunoreactivity in primary and metastatic carcinoma of the liver","volume":"8","author":"Proca D M","year":"2000","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(03)00008-X"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198803000-00004"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2002.01622.x"},{"issue":"2","key":"e_1_2_6_30_2","first-page":"139","article-title":"Blood\u2010group\u2010related antigen Lewis(x) and Lewis(y) in the differential diagnosis of cholangiocarcinoma and hepatocellular carcinoma","volume":"113","author":"Jovanovic R","year":"1989","journal-title":"Arch Pathol Lab Med"},{"issue":"57","key":"e_1_2_6_31_2","first-page":"839","article-title":"A mixed hepatocellular carcinoma and cholangiocarcinoma","volume":"51","author":"Tanaka S","year":"2004","journal-title":"dual expression of biliary-type cytokeratin and hepatocyte specific marker"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.130104"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.90"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2005.01100.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2005.01100.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T17:22:43Z","timestamp":1706548963000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2005.01100.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,13]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1478-3231.2005.01100.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2005.01100.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,13]]}}}